Stock listing

LS Exchange:A1137V Theravance Biopharma, Inc. Aktie

German listing (LS Exchange) of Theravance Biopharma, Inc. · home listing NASDAQ:TBPH

Follow Theravance Biopharma, Inc. into a list and get an email when it puts out news.

Theravance Biopharma, Inc. logo
Ticker
LS Exchange:A1137V
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Calls

Replays

  • Theravance Biopharma (NASDAQ:TBPH) Q1 2026 Earnings Call

    Mon, Dec 08, 2025

    Watch Transcript

  • Theravance Biopharma (NASDAQ:TBPH) Q3 2025 Earnings Call

    Mon, Nov 10, 2025 · 5:00 PM ET

    Watch Transcript

  • Theravance Biopharma (NASDAQ:TBPH) Q2 2025 Earnings Call

    Tue, Aug 12, 2025 · 5:00 PM ET

    Watch Transcript

Latest news

Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 10, 2026

Theravance Biopharma enters into definitive agreement to be acquired by Zymeworks for $17.00 per share in cash plus a contingent value right

Jun 29, 2026

Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 7, 2026

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Mar 19, 2026

Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions

Mar 3, 2026

Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025

Nov 20, 2025

Theravance Biopharma to Participate in Upcoming Investor Conferences

Nov 19, 2025

Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Oct 29, 2025

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 27, 2025

All Theravance Biopharma, Inc. news

Decks

Theravance Biopharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 125 in all · newest Aug 10, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Dec 8, 2025
Decks
80 decks · latest Aug 25, 2026

Where Theravance Biopharma, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TBPH · Home listingNASDAQUnited StatesUSD
gettex:0TBgettexGermanyEUR
LS Exchange:A1137V · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A1137VLang & SchwarzGermanyEUR
BOATS:TBPHBOATSUnited StatesUSD
Frankfurt:0TBFrankfurtGermanyEUR
Dusseldorf:0TBDusseldorfGermanyEUR
Stuttgart:0TBStuttgartGermanyEUR
Tradegate:0TBTradegateGermanyEUR

Log in to ask 6ix AI your own questions about Theravance Biopharma, Inc.